What is the treatment for Rhabdomyolysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Rhabdomyolysis

The cornerstone of rhabdomyolysis treatment is aggressive fluid resuscitation with isotonic saline at 200-300 mL/hour until creatine kinase (CK) levels decrease to <1,000 U/L, with close monitoring of electrolytes, renal function, and urine output every 12-24 hours. 1

Initial Management

Fluid Resuscitation

  • Begin immediate IV fluid therapy with isotonic saline (0.9% NaCl)
    • Target rate: 200-300 mL/hour
    • Goal: Achieve urine output of 300 mL/hour 2
    • Continue until CK levels decrease to <1,000 U/L 1

Monitoring Parameters

  • Check electrolytes, renal function, and urine output every 12-24 hours 1
  • Monitor for:
    • Hyperkalemia (>6.0 mEq/L)
    • Metabolic acidosis
    • Volume overload
    • Compartment syndrome
    • Disseminated intravascular coagulation 2

Management of Complications

Hyperkalemia Management

  • Discontinue potassium-containing fluids
  • Stop nephrotoxic medications 1
  • For severe hyperkalemia (>6.0 mEq/L):
    • Consider calcium gluconate, insulin with glucose, sodium bicarbonate, or potassium-binding resins
    • Monitor ECG for cardiac effects of hyperkalemia

Acute Kidney Injury

  • Early recognition and aggressive fluid therapy are essential
  • Avoid nephrotoxic agents including NSAIDs and aminoglycosides
  • Consider nephrology consultation for:
    • Significantly elevated CK levels
    • Signs of developing acute kidney injury
    • Potential need for renal replacement therapy 1

Special Considerations

Renal Replacement Therapy

  • Consider on a case-by-case basis for:
    • Persistent hyperkalemia (>6.0 mEq/L)
    • Severe metabolic acidosis (pH <7.1)
    • Volume overload unresponsive to diuretics
    • Uremic symptoms
    • Rapidly rising BUN/creatinine levels 1, 2

Medications with Limited Evidence

  • Bicarbonate and mannitol do not have strong evidence for improved outcomes 2
  • Loop diuretics may be considered for volume overload but not as primary therapy 2

Addressing Underlying Causes

  • Identify and treat the underlying etiology:
    • Discontinue causative medications or toxins
    • Treat infections
    • Correct metabolic and endocrine disorders
    • Address trauma-related issues 3, 4

Disposition

  • Most patients require hospital admission for monitoring and continued treatment
  • Discharge may be appropriate for select patients with:
    • Mild elevation of CK
    • No evidence of renal dysfunction
    • No electrolyte abnormalities
    • Ability to maintain adequate oral hydration 2

Pitfalls and Caveats

  • Delayed recognition can lead to preventable complications
  • The classic triad of myalgias, weakness, and pigmenturia is present in less than 10% of cases 4
  • Mortality is significantly higher in patients who develop acute renal failure
  • Risk of acute renal failure increases when CK levels exceed 16,000 IU/L 4
  • Avoid potassium-containing balanced salt fluids which may worsen hyperkalemia 1
  • Watch for complications of aggressive fluid therapy, including volume overload and electrolyte imbalances

References

Guideline

Kidney Function and Blood Urea Nitrogen (BUN) Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The other medical causes of rhabdomyolysis.

The American journal of the medical sciences, 2003

Research

Rhabdomyolysis: review of the literature.

Neuromuscular disorders : NMD, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.